As a comparison, deletion of both CD4+ and CD8+ T cells (GK1.5+2.43) ablated both improved mouse survival and suppressed tumour growth (Fig. 3e) by combination therapy, pointing to critical roles of CD4+ and CD8+ T cells in this process. This evidence concerns the gene CD8A and neoplasm.